Back
HFA Premium Access

Baseline characteristics and alterations after initiation of therapy with SGLT2i in a real-world heart failure with reduced ejection fraction population

Session: ePosters in chronic heart failure - treatment 2
Topic: Treatment
Speaker: Doctor A. Stavrati (Thessaloniki, GR)
Event: Heart Failure 2023

Congress Presentation

About the speaker

Doctor Alexia Stavrati

General Hospital G. Papanikolaou, Thessaloniki (Greece)
2 presentations
2 followers

5 more presentations in this session

Impact of early initiation of mTOR inhibitors on long-term survival outcome after heart transplantation: data from the nationwide Korean Organ Transplant Registry (KOTRY)

Speaker: Professor H. Cho (Seoul, KR)

Access
Abstract
Slides
Thumbnail

Kidney dysfunction correlates with worse response to levosimendan treatment

Speaker: Doctor F. Gerardo (Amadora, PT)

Access
Abstract
Slides
Thumbnail

A year in the life of diuretic usage in an outpatient heart failure unit

Speaker: Doctor D. O'Flynn (Dublin, IE)

Access
Abstract
Slides
Thumbnail

Long-term clinical impact of nutritional intervention in patients with acute heart failure

Speaker: Assistant Professor K. Choi (Seoul, KR)

Access
Abstract
Slides
Thumbnail

Adjustments in furosemide dose in patients with heart faillure receiving SGLT2is-does HbA1c matter?

Speaker: Doctor M. Stratinaki (Heraklion, GR)

Access
Abstract
Slides
Thumbnail

Access the full session

ePosters in chronic heart failure - treatment 2

Speakers: Doctor A. Stavrati, Professor H. Cho, Doctor F. Gerardo, Doctor D. O'Flynn, Assistant Professor K. Choi...
Access
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb